Coloplast sees potential in Russia

For 20 years, Coloplast has operated on the Russian market, which is highly competitive, not least due to local companies getting special treatment from authorities, according to country manager.

Photo: Coloplast / PR

Russia imports 75 percent of all medical equipment, which Coloplast highly benefits from, according to a recent newsletter from the Confederation of Danish Industry (DI).

The Danish medtech company has been active on the Russian market for 20 years, although it is disadvantaged by the fact that it has no production in the country, since Russian authorities give preferential treatment to local enterprises, which Coloplast General Director and Country Manager, Rus cluster, Dmitry Tsarapkin tells DI.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs